Clinical Trials Directory

Trials / Completed

CompletedNCT05344196

Emotional Awareness and Expression Therapy for Prediabetes

Examining the Effect of a Novel Stress Reduction Intervention no the Control of Prediabetes: A Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Wayne State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.

Detailed description

Prediabetes is a clinical condition in which hemoglobin A1C is between 5.6 and 6.4, and is usually associated with being overweight, poor diet, limited exercise, and psychological stress. This condition develops in to Type II diabetes in many people, and interventions to prevent such progression are needed. Because stress can directly negative impact blood glucose metabolism and can indirectly affect it through unhealthy behaviors (e.g., diet, exercise), it may be possible to reduce stress and improve clinical outcomes. Although most stress management approaches help people to calm their physiology and reduce their negative emotions, another approach to stress treatment is to help people disclose emotionally difficult experiences, become aware of and express their emotions, and change interpersonal relationships by becoming more assertive as well as more open/connected. Emotional Awareness and Expression Therapy (EAET) is an approach to stress reduction that uses these principles and it has been shown to be effective for somatic symptom disorders like chronic pain. In this study, we will adapt EAET to the prediabetes context and test its feasibility, acceptability and initial efficacy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModified EAET for prediabetesAttempts to reduce stress and improve health behavior by engaging in emotional awareness and expression leading to changes in interpersonal relationships and health behavior

Timeline

Start date
2022-03-01
Primary completion
2022-12-15
Completion
2022-12-15
First posted
2022-04-25
Last updated
2023-01-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05344196. Inclusion in this directory is not an endorsement.